Outcome
    Limited

    CoQ10 for Cardiovascular Risk Reduction

    CoQ10 supplementation shows small blood pressure reductions in meta-analyses and improved outcomes in one heart failure trial (Q-SYMBIO). For general cardiovascular prevention, evidence is supportive but not definitive.

    Overview

    CoQ10 supplementation shows small blood pressure reductions in meta-analyses and improved outcomes in one heart failure trial (Q-SYMBIO). For general cardiovascular prevention, evidence is supportive but not definitive.

    Verdict

    Mixed evidence

    CoQ10 modestly lowers blood pressure and may reduce statin muscle symptoms; event-reduction evidence is limited.

    How It Works

    Mitochondrial electron transport cofactor; antioxidant protection of LDL; endothelial function support.

    Dosing & Protocol

    Typical dose

    Recommended dose
    100-300 mg/day with fat-containing meals
    Expected timeframe
    Months to years; event-level benefit was measured over 2 years in the supporting trials

    Protocol

    dose
    100-300 mg/day, divided above 200 mg
    form
    Ubiquinone or ubiquinol softgel
    steps
    Prioritise the interventions with hard outcome data first: blood pressure control, statin therapy where indicated, not smoking, and physical activity. CoQ10 does not substitute for any of them.,If adding CoQ10, take 100 mg twice daily with fat-containing meals.,Note the honest state of evidence: the Q-SYMBIO heart failure trial showed reduced major cardiovascular events, and the KiSel-10 trial (CoQ10 plus selenium in older Swedes) reported reduced cardiovascular mortality — but these are specific populations, and broader primary-prevention data are weak.,Keep monitoring blood pressure and lipids; CoQ10 does not meaningfully lower LDL.,Reassess annually with your clinician.
    timing
    With meals containing fat
    duration
    Long-term; event-reduction data come from 2-year trials

    Evidence

    No studies are yet linked to both CoQ10 and Cardiovascular Risk Reduction.

    Safety

    Caveats

    Mixed verdict: positive event data come from heart failure and one selenium-co-supplemented elderly cohort, not from general primary prevention. CoQ10 interferes with warfarin — monitor INR. Additive hypotension with antihypertensives. It does not lower LDL cholesterol and is not a statin alternative. Insufficient pregnancy data.

    Less likely to help if

    Healthy people at low baseline risk, and anyone using CoQ10 in place of blood pressure or lipid treatment.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.